avexitide
avexitide: sourced relationships with 2 companies · 2 clinical trials tracked.
avexitide evidence translation
What we can confirm
2 tracked trials
What it means
What to watch
Prepared research question
What is verified about avexitide, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Dated Pipeline Records (2)
| Company | Dated record stage |
|---|---|
| Amylyx Pharmaceuticals, Inc. (AMLX) Post-bariatric Hypoglycemia; Post Bariatric Hypoglycemia | Phase 3 |
| Eiger BioPharmaceuticals, Inc. (EIGR) Congenital hyperinsulinism (HI) and post-bariatric hypoglyce… | Phase 3 |
Clinical Trial Registry Records (2)
An Expanded Access Protocol to Provide Avexitide in Patients With Post-Bariatric Hypoglycemia
A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Avexitide in Participants With Post-Bariatric Hypoglycemia
Primary endpoint: Composite rate of Level 2 and Level 3 hypoglycemic events
Frequently asked questions
Which companies have sourced relationships with avexitide?
avexitide has dated SEC/FDA relationship records for Amylyx Pharmaceuticals, Inc., Eiger BioPharmaceuticals, Inc..
How many clinical trials involve avexitide?
BioSniper tracks 2 clinical trials involving avexitide.